普洛药业：与嘉兴安帝康生物科技签署战略合作框架协议

Core Viewpoint - Pro Pharmaceutical (000739) has signed a strategic cooperation framework agreement with Jiaxing Andikang Biotechnology to enhance long-term collaboration in innovative drug development, aiming to strengthen industry competitiveness and improve market supply capabilities [1] Company Summary - Pro Pharmaceutical is actively seeking to establish a strategic partnership with Jiaxing Andikang Biotechnology to explore more long-term projects in the field of innovative drugs [1] - The collaboration is focused on building competitive advantages in the pharmaceutical market and ensuring stable supply capabilities [1] Industry Summary - The agreement reflects a trend in the pharmaceutical industry towards strategic partnerships aimed at enhancing innovation and competitiveness [1] - The collaboration may lead to the development of new drug projects that could strengthen the overall market position of both companies [1]